ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Educational Symposium

Glucagon-Like Peptide-1 Receptor Agonists Are Becoming Important Players in Diabetic Kidney Disease

November 04, 2023 | 12:45 PM - 01:45 PM

Location: Grand Ballroom Salon I, Level 5, Philadelphia Marriott Downtown

Session Description

Glucagon-like peptide-1 receptor agonists (GLP1 RAs) have shown favorable profiles in type 2 diabetes as glucose-lowering medications. Furthermore, evidence is growing, based on multiple clinical trials with GLP1 RAs, to suggest favorable profiles in subjects with diabetic or other chronic kidney diseases and possible renoprotection.

This symposium provides an overview of recent, large clinical trials with GLP1 RAs in subjects with type 2 diabetes, focusing on kidney outcomes in particular. Furthermore, GLP1 RA use is discussed in the context of other glucose-lowering or renoprotective treatment.

Support is provided by an educational grant from Novo Nordisk.

Learning Objective(s)

  • Describe recent, large clinical trials on GLP1 RAs in type 2 diabetes
  • Summarize kidney outcomes in recent clinical trials
  • Discuss GLP1 RAs in the context of other treatments for diabetic kidney disease

Learning Pathway(s)

  • Diabetic Kidney Disease
  • CKD Non-Dialysis